Impax Lab Revenue, Profits - IPXL Quarterly Income Statement

Add to My Stocks
$20.45 $0.6 (2.85%) IPXL stock closing price Mar 19, 2018 (Closing)

Financial analysis of Impax Lab involves more than just checking the Impax Lab stock price, by looking at the financial statements of the company in detail. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the IPXL stock is bound to reflect the impact of the QOQ growth of 2.13%. Revenue for year 2017 Q3 is $206.39M and has increased from $202.08M quarter on quarter as is evident when you compare the latest figures in the latest Impax Lab profit and loss statement with those of the prior corresponding period. Also see Impax Lab assets and Impax Lab free cash flow for a complete valuation of IPXL stock.

View and download details of revenue and profits for Impax Lab for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Impax Lab Revenues or Net Sales
Cost Of Goods Sold (COGS)172.35M129.67M159.51M359.69M393.33M99.6M122.91M167.32M127.55M
Impax Lab Gross Profit
Research & Development Expense15.82M26.84M28.56M43.79M48.88M21.74M19.02M26.4M18.63M
Selling General & Admin Expense55.22M52.78M48.12M58.89M58.31M46.83M45.61M57.58M47.35M
Income Before Depreciation Depletion Amortization-37.01M-7.22M-51.8M-263.91M-272.62M4.4M37.95M30.8M27.55M
Depreciation Depletion Amortization---------
Non Operating Income-1.76M-0.34M-2.34M6.46M-0.15M--47.11M-9.36M41.95M
Interest Expense13.63M13.36M13.38M13.58M11.08M8.45M8.33M8.16M8.18M
Impax Lab Pretax Income
Provision for Income Taxes-3.04M-0.52M30.9M8.56M-104.53M-1.24M-7.08M1.86M25.57M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-49.37M-20.42M-98.43M-279.59M-179.34M-2.7M-10.41M11.43M35.76M
Extraordinary Items & Discontinued Operations---------
Impax Lab Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS71.93M71.8M71.6M71.49M71.33M71.1M70.67M72.04M72.78M
Average Shares used to compute Basic EPS71.93M71.8M71.6M71.49M71.33M71.1M70.67M70.42M69.82M
Income Before Nonrecurring Items16.68M13.14M7.73M11.65M26.15M15.01M30.85M44.52M29.21M
Income from Nonrecurring Items-66.05M-33.56M-106.16M-291.23M-205.49M-17.71M-41.26M-33.09M6.55M
Impax Lab Earnings Per Share Basic Net
Impax Lab Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Impax Lab stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Impax Lab revenue chart, implies that the company is growing. It has been the case with Impax Lab. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Impax Lab try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The IPXL financials along with Impax Lab historical stock prices provide a lot of details about the firm.

Impax Lab Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield